Modulation of In Vivo Cardiac Function by Myocyte-Specific Nitric Oxide Synthase-3

Circulation Research

Volumn 94, Issue 5, 2004, Pages 657-663

  Champion, Hunter C ^a   Georgakopoulos, Dimitrios ^a   Takimoto, Eiki ^a   Isoda, Takayoshi ^a   Wang, Yibin ^b   Kass, David A ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

adrenergic; Adenovirus; Hemodynamics; Myocyte; Nitric oxide synthase

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CARBACHOL; CAVEOLIN 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEART ENZYME; ISOPRENALINE; MUSCARINIC AGENT;

ADOLESCENT; ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; DIASTOLE; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME SPECIFICITY; GENETIC TRANSFECTION; HEART DIASTOLIC FUNCTION; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART RATE; HEART SYSTOLIC FUNCTION; HEMODYNAMICS; IN VIVO STUDY; INOTROPISM; MAJOR HISTOCOMPATIBILITY COMPLEX; MODULATION; MOUSE; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONTENT; PROTEIN EXPRESSION; REGULATORY MECHANISM; SYSTOLE;

ADENOVIRIDAE; ADRENERGIC BETA-AGONISTS; ANIMALS; AUTOCRINE COMMUNICATION; CARBACHOL; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; GENETIC VECTORS; HEART RATE; ISOPROTERENOL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCARINIC AGONISTS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 1642339627     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000119323.79644.20     Document Type: Article

References (36)

1. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
2. Hare JM, Lofthouse RA, Juang GJ, Colman L, Ricker KM, Kim B, Senzaki H, Cao S, Tunin RS, Kass DA. Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure. Circ Res. 2000;86:1085-1092.
3. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 1995;92:2198-2203.
4. Cotton JM, Kearney MT, MacCarthy PA, Grocott-Mason RM, McClean DR, Heymes C, Richardson PJ, Shah AM. Effects of nitric oxide synthase inhibition on basal function and the force-frequency relationship in the normal and failing human heart in vivo. Circulation. 2001;104:2318-2323.
5. Gyurko R, Kuhlencordt P, Fishman MC, Huang PL. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol Heart Circ Physiol. 2000;278:H971-H981.
6. Hare JM. Nitric oxide and excitation-contraction coupling. J Mol Cell Cardiol. 2003;35:719-729.
7. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature. 2002;416:337-339.
8. ca-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 1998;95:6510-6515.
9. Sears CE, Bryant SM, Ashley EA, Lygate CA, Rakovic S, Wallis HL, Neubauer S, Terrar DA, Casadei B. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res. 2003;92:e52-e59.
10. Godecke A, Heinicke T, Kamkin A, Kiseleva I, Strasser RH, Decking UK, Stumpe T, Isenberg G, Schrader J. Inotropic response to β-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. J Physiol. 2001;532:195-204,
11. Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I, Fischmeister R. Muscarinic and β-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat Med. 1999;5:331-334,
12. 2+ current is not altered in cardiac ventricular myocytes from mice lacking endothelial nitric oxide synthase. J Physiol. 2000;528:279-289.
13. Brunner F, Andrew P, Wolkart G, Zechner R, Mayer B. Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation. 2001;104:3097-3102.
14. Kaye DM, Wiviott SD, Balligand JL, Simmons WW, Smith TW, Kelly RA. Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes. Circ Res. 1996;78:217-224.
15. Khan SA, Skaf MW, Harrison RW, Lee K, Minhas KM, Kumar A, Fradley M, Shoukas AA, Berkowitz DE, Hare JM. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res. 2003;92:1322-1329.
16. Champion HC, Georgakopoulos D, Haldar S, Wang L, Wang Y, Kass DA. Robust adeno- and adeno-associated viral gene transfer to the in vivo murine heart: application to study of in vivo phospholamban physiology. Circulation. 2003;108:2790-2797.
17. Champion HC, Bivalacqua TJ, D'Souza FM, Ortiz LA, Jeter JR, Toyoda K, Heistad DD, Hyman AL, Kadowitz PJ. Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo: effect on agonist-induced and flow-mediated vascular responses. Circ Res. 1999;84:1422-1432.
18. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T. Endothelial nitric oxide synthase targeting to caveolae: specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem. 1996;271:22810-22814.
19. Georgakopoulos D, Kass D. Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart. J Physiol. 2001;534:535-545.
20. Feron O, Belhassen L, Kobzik L, Smith TM, Michel T. Endothelial nitric oxide synthase targeting to caveolae: Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem. 1996;271:22810-2214.
21. Sharir T, Feldman MD, Haber H, Feldman AM, Marmor A, Becker LC, Kass DA. Ventricular systolic assessment in patients with dilated cardiomyopathy by preload-adjusted maximal power: validation and noninvasive application. Circulation. 1994;89:2045-2053.
22. Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW, Michel T. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem. 1995;270:14582-14586.
23. Paolocci N, Ekelund UE, Isoda T, Ozaki M, Vandegaer K, Georgakopoulos D, Harrison RW, Kass DA, Hare JM. cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation. Am J Physiol Heart Circ Physiol. 2000;279:H1982-H1988.
24. Campbell DL, Stamler JS, Strauss HC. Redox modulation of L-type calcium channels in ferret ventricular myocytes: dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol. 1996;108:277-293.
25. Xu L, Eu JP, Meissner G, Stamler JS. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science. 1998;279:234-237.
26. 2+ release in cardiomyocytes. Nat Cell Biol. 2001;3:867-873.
27. Massion PB, Balligand JL. Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. J Physiol. 2003;546:63-75.
28. Paulus WJ, Shah AM. NO and cardiac diastolic function. Cardiovasc Res. 1999;43:595-606.
29. Gyurko R, Kuhlencordt P, Fishman MC, Huang PL. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol. 2000;278:H971-H981.
30. Layland J, Li JM, Shah AM. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol. 2002;540:457-467.
31. Mohan RM, Heaton DA, Danson EJ, Krishnan SP, Cai S, Channon KM, Paterson DJ. Neuronal nitric oxide synthase gene transfer promotes cardiac vagal gain of function. Circ Res. 2002;91:1089-1091.
32. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415:198-205.
33. Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A. 1999;96:657-662.
34. 2+-ATPase. Circ Res. 1997;81:145-153.
35. Meyer M, Bluhm WF, He H, Post SR, Giordano FJ, Lew WY, Dillmann WH. Phospholamban-to-SERCA2 ratio controls the force-frequency relationship. Am J Physiol. 1999;276:H779-H785.
36. Kadambi VJ, Ball N, Kranias EG, Walsh RA, Hoit BD. Modulation of force-frequency relation by phospholamban in genetically engineered mice. Am J Physiol. 1999;276:H2245-H2250.